What's breaking now, across thousands of outlets.
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world. (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
The Colt Group represents Leichtman Capital Partners VII’s fifth platform investment. The post LLCP acquires the Colt Group appeared first on PE Hub .
A diesel-price shock may be approaching Western economies. That's because the industrial fuel sits at the epicenter of freight, agriculture, construction, and heavy industry; soaring prices ripple…
The operation is expected to average 41 million lb. of copper, 20,000 oz. of gold and 444,000 oz. of silver annually.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their…